Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Kalakonda N, Maerevoet M, Cavallo F. et al
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.

Lancet Haematol 2020;
7 (07) e511-e522

Bibliographische Angaben herunterladen

Aufrufen in: